Author:
Fung Anne E.,Lalwani Geeta A.,Rosenfeld Philip J.,Dubovy Sander R.,Michels Stephan,Feuer William J.,Puliafito Carmen A.,Davis Janet L.,Flynn Harry W.,Esquiabro Maria
Reference8 articles.
1. VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group;Gragoudas;N Engl J Med,2004
2. Ranibizumab for neovascular age-related macular degeneration;Rosenfeld;N Engl J Med,2006
3. Ranibizumab vs verteporfin for neovascular age-related macular degeneration;Brown;N Engl J Med,2006
4. Preliminary results from a phase IIIb study showed patients with wet AMD treated with Lucentis quarterly experienced a 16-letter benefit over the control group at one year. [press release]. South San Francisco, California: Genentech; June 2, 2006. Available at: http://www.gene.com/gene/news/press-releases/display.do?method=detail&id=9747. Accessed Date: August 26, 2006.
5. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen;Chen;J Mol Biol,1999
Cited by
860 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献